DuPont
DD NYSE Industrial Conglomerates Financials FY2016–FY2025
DuPont's revenue rose 1.9% to $6.8 billion in fiscal 2025. Its net margin was −11.4%, down from 10.5% a year earlier. Free cash flow was $227 million, down 52.7%. It paid out $597 million in dividends and buybacks, 263% of free cash flow.
About these figures. Share counts and per-share figures for earlier years are restated for a stock split (1-for-3.003), so every year is on today's share basis.
What DuPont does
DuPont makes engineered materials and parts for other businesses. Its products include medical packaging and components for medical devices and drug makers, water filters and membranes that clean water for industry and cities, building materials such as TYVEK house wrap, STYROFOAM insulation and CORIAN countertops, and industrial parts, adhesives, lubricants and printing plates for aircraft, car and packaging makers. It has subsidiaries in about 50 countries and factories in about 20.
It reports two segments. Healthcare & Water Technologies had net sales of $3,233 million in 2025, and Diversified Industrials, which covers the building and industrial products, had $3,616 million. Sales outside the US, including exports, made up about 53 percent of the total. DuPont says it competes with large multinational companies and established regional ones, on technology, price and service.
The company has been shrinking to this core. On November 1, 2025 it spun off its electronics business as a separate public company, Qnity Electronics, and it has agreed to sell its Aramids business to Arclin, a deal it said it expected to close around the end of the first quarter of 2026. At the end of 2025 DuPont employed about 15,000 people, about 1,700 of them in the Aramids business, and half of its workforce was in the US and Canada.
- Legal name
- DUPONT DE NEMOURS, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 17, 2026
- Accession · CIK
- 0001666700-26-000013
0001666700
Revenue and margins
DuPont had $6.8B of revenue in fiscal 2025, up 1.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $227M in fiscal 2025, 3.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
DuPont returned $597M to shareholders in fiscal 2025, 263% of free cash flow. The diluted share count rose 0.0%.
Value DuPont yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.
Discounted cash flow
Value per share
—
Adds net cash of −$2.5B and divides by 419.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Balance sheet
Cash, debt and the ratios that show how comfortably DuPont can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.0B | $5.0B | $2.4B | $1.8B | $715M |
| Debt incl. finance leases | $10.8B | $8.1B | $7.9B | $7.2B | $3.2B |
| Net debt / EBITDA | 2.9x | 1.0x | 7.8x | 4.8x | 2.1x |
| Debt / equity | 0.4x | 0.3x | 0.3x | 0.3x | 0.2x |
| Interest coverage | 3.8x | 3.9x | 0.3x | 1.3x | 1.6x |
| Current ratio | 2.9x | 3.0x | 2.4x | 3.8x | 2.4x |
| Quick ratio | 2.5x | 2.4x | 1.7x | 3.6x | 1.9x |
| Total assets | $45.7B | $41.4B | $38.6B | $36.6B | $21.6B |
| Total liabilities | $18.7B | $14.3B | $13.8B | $12.8B | $7.5B |
| Shareholders' equity | $26.4B | $26.6B | $24.3B | $23.4B | $13.9B |
| Net debt (− = net cash) | $8.8B | $3.2B | $5.5B | $5.4B | $2.5B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.6M
2 insiders
Of sales under plans
0%
$0.0M
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✕ |
| Cash from operations is positive | ✓ | ✓ | ✓ |
| Return on assets rose | ✕ | ✓ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ |
| Debt fell relative to assets | ✕ | ✓ | ✓ |
| Current ratio rose | ✕ | ✓ | ✕ |
| Share count didn't rise | ✓ | ✓ | ✓ |
| Gross margin rose | ✕ | ✓ | ✓ |
| Revenue rose relative to assets | ✕ | ✓ | ✓ |
| F-score | 4 / 9 | 9 / 9 | 6 / 9 |
| Accruals ratio | −1.1% | −0.2% | −4.6% |
| Altman Z'' | 0.72 | 2.72 | −0.53 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| DuPont DD | $18.7B | 1.9% | — | 3.3% | 1.1% | — | 6 | |
| Carlisle Companies CSL | $14.0B | 0.3% | 20.0% | 19.3% | 21.9% | 19.8x | 6 | Compare → |
| 3M MMM | $90.7B | 1.5% | 18.6% | 5.6% | 34.2% | 25.9x | 5 | Compare → |
| Honeywell Technologies HON | $70.6B | 7.9% | 21.7% | 14.5% | 17.1% | 15.0x | 4 | Compare → |
| ZIM Integrated Shipping ZIM | $3.5B | −18.1% | 14.7% | 30.2% | 24.9% | — | 4 | Compare → |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $48.2B | $11.7B | $22.6B | $21.5B | $20.4B | $12.6B | $13.0B | $6.6B | $6.7B | $6.8B |
| Gross profit | $10.5B | $12.7B | $20.6B | $11.5B | $13.3B | $4.6B | $4.6B | $2.2B | $2.2B | $2.4B |
| Research and development | $1.6B | $657M | $1.1B | $689M | $565M | $557M | $536M | $192M | $203M | $193M |
| Interest expense | $858M | $0.0M | $55.0M | $667M | $672M | $525M | $492M | $396M | $366M | $313M |
| Pretax income | $4.4B | −$1.5B | $600M | −$126M | −$1.3B | $1.4B | $1.4B | −$279M | $117M | $200M |
| Income tax | $9.0M | −$1.8B | $195M | −$2.0M | $90.0M | $237M | $387M | −$217M | $213M | $102M |
| Net income | $4.3B | $1.2B | $3.8B | $498M | −$3.0B | $6.5B | $5.9B | $423M | $703M | −$779M |
| Diluted EPS | $10.56 | $2.15 | $4.96 | $0.67 | −$4.01 | $11.89 | $11.75 | $0.94 | $1.68 | −$1.86 |
| Diluted shares | 0.37B | 0.53B | 0.77B | 0.75B | 0.74B | 0.54B | 0.50B | 0.45B | 0.42B | 0.42B |
| Cash flow | ||||||||||
| Cash from operations | −$3.0B | −$765M | $4.7B | $1.4B | $4.1B | $2.3B | $588M | $845M | $765M | $560M |
| Capital expenditure | $3.8B | $551M | $1.2B | $2.5B | $1.2B | $788M | $662M | $302M | $285M | $333M |
| Free cash flow | −$6.8B | −$1.3B | $3.5B | −$1.1B | $2.9B | $1.5B | −$74.0M | $543M | $480M | $227M |
| Depreciation and amortization | $2.9B | $1.1B | $2.2B | $3.2B | $3.1B | $1.1B | $1.1B | $580M | $635M | $647M |
| Stock-based compensation | $261M | $19.0M | $92.0M | $87.0M | $93.0M | $67.0M | $75.0M | $57.0M | $56.0M | $38.0M |
| Acquisitions | $187M | $50.0M | $20.0M | $180M | $70.0M | $2.3B | $5.0M | $1.8B | $313M | $55.0M |
| Share buybacks | $916M | $1.0B | $4.4B | $2.3B | $232M | $2.1B | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $2.5B | $3.4B | $3.5B | $1.6B | $882M | $630M | $652M | $651M | $635M | $597M |
| Dividends and buybacks | $3.4B | $4.4B | $7.9B | $3.9B | $1.1B | $2.8B | $652M | $651M | $635M | $597M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $6.6B | $14.4B | $8.6B | $1.5B | $2.5B | $2.0B | $5.0B | $2.4B | $1.8B | $715M |
| Total debt | $21.4B | $34.1B | −$12.6B | −$11.8B | $15.6B | $10.8B | $8.1B | $7.9B | $7.2B | $3.2B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $3.0M | $2.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $23.7B | $49.9B | $126.7B | $10.0B | $29.0B | $14.3B | $11.3B | $7.5B | $20.8B | $5.6B |
| Current liabilities | $12.6B | $26.1B | $73.3B | $8.3B | $12.2B | $4.9B | $3.7B | $3.1B | $5.5B | $2.3B |
| Inventory | $7.4B | $17.0B | $4.1B | $4.3B | $2.4B | $2.1B | $2.3B | $2.1B | $1.1B | $1.2B |
| Property and equipment, net | $23.5B | $36.2B | $9.9B | $10.1B | $10.0B | $5.8B | $5.7B | $5.9B | $3.5B | $3.5B |
| Total assets | $79.5B | $191.9B | $187.9B | $69.3B | $70.9B | $45.7B | $41.4B | $38.6B | $36.6B | $21.6B |
| Total liabilities | $52.3B | $90.5B | $92.0B | $27.8B | $31.8B | $18.7B | $14.3B | $13.8B | $12.8B | $7.5B |
| Shareholders' equity | $26.0B | $100.3B | $94.3B | $41.0B | $38.5B | $26.4B | $26.6B | $24.3B | $23.4B | $13.9B |
| Margins | ||||||||||
| Gross margin | 21.8% | 108.8% | 91.4% | 53.4% | 65.4% | 36.6% | 35.5% | 32.8% | 33.0% | 34.5% |
| EBITDA margin | 16.9% | −4.0% | 12.5% | 17.4% | 12.3% | 24.5% | 23.6% | 10.5% | 16.6% | 16.9% |
| Net margin | 9.0% | 9.9% | 17.0% | 2.3% | −14.5% | 51.5% | 45.1% | 6.4% | 10.5% | −11.4% |
| FCF margin | −14.0% | −11.3% | 15.4% | −4.9% | 14.2% | 11.9% | −0.6% | 8.2% | 7.1% | 3.3% |
| Returns | ||||||||||
| Return on capital | — | −1.5% | 0.5% | 0.8% | −1.2% | 3.7% | 4.3% | 0.3% | 0.8% | 1.1% |
| Return on capital employed | — | −1.3% | 0.5% | 0.6% | −1.0% | 4.0% | 5.0% | 0.3% | 1.5% | 2.0% |
| Return on equity | 16.6% | 1.8% | 4.0% | 0.7% | −7.4% | 19.9% | 22.1% | 1.7% | 3.0% | −4.2% |
| Return on assets | 5.9% | 0.9% | 2.0% | 0.4% | −4.2% | 11.1% | 13.5% | 1.1% | 1.9% | −2.7% |
| Growth | ||||||||||
| Revenue growth | −1.3% | −75.8% | 93.6% | −4.8% | −5.2% | −38.4% | 3.6% | −49.2% | 1.6% | 1.9% |
| Net income growth | −43.8% | −73.2% | 231.8% | −87.1% | −692.6% | — | −9.3% | −92.8% | 66.2% | −210.8% |
| EPS growth | −42.8% | −79.6% | 130.7% | −86.5% | −698.5% | — | −1.2% | −92.0% | 78.7% | −210.7% |
| FCF growth | −273.2% | — | — | −130.5% | — | −48.5% | −105.0% | — | −11.6% | −52.7% |
| Share count change | −9.5% | 42.3% | 44.9% | −3.3% | −1.5% | −26.0% | −8.2% | −9.9% | −6.8% | 0.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.8x | — | −7.5x | −3.6x | 5.2x | 2.9x | 1.0x | 7.8x | 4.8x | 2.1x |
| Debt / equity | 0.8x | 0.3x | −0.1x | −0.3x | 0.4x | 0.4x | 0.3x | 0.3x | 0.3x | 0.2x |
| Interest coverage | 6.1x | — | 11.9x | 0.8x | −0.9x | 3.8x | 3.9x | 0.3x | 1.3x | 1.6x |
| Current ratio | 1.9x | 1.9x | 1.7x | 1.2x | 2.4x | 2.9x | 3.0x | 2.4x | 3.8x | 2.4x |
| Quick ratio | 1.3x | 1.3x | 1.7x | 0.7x | 2.2x | 2.5x | 2.4x | 1.7x | 3.6x | 1.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 7.9% | 4.7% | 5.5% | 11.5% | 5.9% | 6.3% | 5.1% | 4.6% | 4.2% | 4.9% |
| Stock comp / revenue | 0.5% | 0.2% | 0.4% | 0.4% | 0.5% | 0.5% | 0.6% | 0.9% | 0.8% | 0.6% |
| Payouts / FCF | — | — | 226.9% | — | 38.4% | 185.7% | — | 119.9% | 132.3% | 263.0% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 4.0 | 5.0 | 5.0 | 6.0 | 6.0 | 6.0 | 4.0 | 9.0 | 6.0 |
| Altman Z'' | 3.2 | 2.4 | 3.5 | 1.4 | 2.3 | 1.5 | 1.8 | 0.7 | 2.7 | −0.5 |
| Accruals ratio | 9.9% | 1.4% | −0.5% | −0.7% | −10.1% | 7.2% | 12.1% | −1.1% | −0.2% | −4.6% |
Source: SEC EDGAR XBRL filings (CIK 0001666700). Data updated October 10, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.